Morgan Stanley says flu vaccine data is likely to boost Moderna's stock

Jakub Porzycki | NurPhoto | Getty Images

Moderna's vaccine platform may have another success story in the pipeline, according to Morgan Stanley.

More In Street Calls

CNBC ProHere are Friday's biggest analyst calls of the day: Apple, FedEx, Coinbase, Honeywell, Micron & more
CNBC ProEnergy stocks are the best bet in the market right now, says JPMorgan
CNBC ProBank of America downgrades Micron, says recovery is 'unlikely' this year